GLP-1 drugs , or glucagon-like peptide-1 receptor agonists , represent a truly innovation in how we approach type 2 diabetes . These injectable drugs help mimicking the body’s own GLP-1 substance , which https://kobijjwp015569.blogpixi.com/42296545/glp-1-a-significant-advance-in-glucose-care